Management of severe hypoglycaemia: Cultural similarities, differences and resource consumption in three European countries

Journal of Medical Economics

Volumn 12, Issue 4, 2009, Pages 269-280

  Lammert, M ^a   Hammer, M ^a   Frier, B M ^b  

^a NOVO NORDISK A S   (Denmark)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Diabetes; Healthcare resource; Hypoglycaemia; Insulin treated diabetes

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AWARENESS; BEHAVIOR CHANGE; BODY MASS; CARBOHYDRATE INTAKE; CONTROLLED STUDY; CULTURAL FACTOR; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; EMERGENCY CARE; EMERGENCY WARD; EMPLOYMENT STATUS; FAMILY; FEMALE; FRIEND; GERMANY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; SELF MEDICATION; SEVERE HYPOGLYCEMIC EVENT; SEX DIFFERENCE; SPAIN; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-CULTURAL COMPARISON; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; FEMALE; GERMANY; GREAT BRITAIN; HEALTH SERVICES; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; YOUNG ADULT;

EID: 72749110044     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990903310501     Document Type: Article

References (27)

1. Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271-286
2. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 1993;10:238-245
3. Stephenson J, Fuller JH, For EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994;37:278-285
4. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in Types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-1147
5. Henderson JN, Allen KV, Deary IJ, et al. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003;20:1016-1021
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
7. Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003;19:232-240 (Pubitemid 36675964)
8. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994;17:697-703.
9. Geddes J, Wright RJ, Zammitt NN, et al. An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care 2007;30:1868-1870 (Pubitemid 47036368)
10. Allicar MP, Mégas F, Houzard S, et al. Frequency and costs of hospital stays for hypoglycemia in France in 1995 [in French]. Presse Med 2000;29:657-661
11. Hart WM, Espinosa C, Rovira J. Costs of known diabetes mellitus in Spain [in Spanish]. Med Clin (Barc) 1997;109:289-293
12. Köster I, Von Ferber L, Ihle P, et al. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM study. Diabetologia 2006;49:1498-1504
13. Frier BM. Impaired awareness of hypoglycaemia. Hypoglycaemia in Clinical Diabetes, 2nd edn. Chichester: John Wiley, 2007;141-170
14. Clarke WL, Cox DJ, Gonder-Frederick LA, et al. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995;18:517-522
15. Geddes J, Schopman J, Zammitt NN, et al. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet Med 2008;25:501-504
16. Schopman J, Geddes J, Frier BM. Awareness of hypoglycaemia in patients with insulin-treated diabetes. Diabet Med 2008;25(Suppl 1):97 [abstract].
17. Brunton SA Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs. MedGenMed 2007;9:38.
18. Allen KV, McAulay V, Sommerfield AJ, et al. Hypoglycaemia is uncommon with a combination of antidiabetic drugs and bedtime NPH insulin for type 2 diabetes. Pract Diabetes Int 2004;21:179-182
19. Strachan MWJ. Frequency, causes and risk factors for hypoglycaemia in type 1 diabetes. Hypoglycaemia in Clinical Diabetes, 2nd edn. Chichester: John Wiley, 2007;49-81.
20. Pedersen-Bjergaard U, Pramming S, Heller SR, et al. Severe hypoglycaemia in 1076 patients with Type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004;20:479-486
21. Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005;22:749-755
22. Mühlhauser I, Overmann H, Bender R, et al. Risk factors of severe hypoglycaemia in adult patients with Type I diabetes - a prospective population based study. Diabetologia 1998;41:1274-1282
23. Huppertz E, Pieper L, Klotsche J, et al. Diabetes mellitus in German primary care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study. Exp Clin Endocrinol Diabetes 2009;117:6-14.
24. Mülhauser I, Bruckner I, Berger M, et al Evaluation of an intensified insulin treatment and teaching programme as routine management of Type 1 (insulin-dependent) diabetes. The Bucharest-Dusseldorf Study. Diabetologia 1987;30:681-690
25. Jörgens V, Grüsser M, Bott U, et al. Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 1993;36:99-105.
26. Holstein A, Egberts EH. Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes. Exp Clin Endocrinol Diabetes 2003;111:405-414
27. Vlckova V, Cornelius V, Kasliwal R, et al. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide. Drug Saf 2009;32:409-418